Dagnon Terry 4
4 · Outlook Therapeutics, Inc. · Filed Apr 21, 2023
Insider Transaction Report
Form 4
Dagnon Terry
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-04-20$1.14/sh−520,000$590,200→ 653,058 total
Footnotes (1)
- [F1]These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.